Perinatal pharmacology of opiates;Pharmacologie perinatale des opiaces

Archives de Pediatrie

Volumn 7, Issue SUPPL. 2, 2000, Pages 287-289

  Marquet, P ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE; DIAMORPHINE; METHADONE; MORPHINE; OPIATE DERIVATIVE; OPIATE RECEPTOR; NARCOTIC AGENT;

BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; CONFERENCE PAPER; DRUG PENETRATION; EMBRYO DEVELOPMENT; HUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; TOXICOKINETICS; ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; FEMALE; NEWBORN; OPIATE ADDICTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; BRAIN; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INFANT, NEWBORN; NARCOTICS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, OPIOID;

EID: 0034182909     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)88747-3     Document Type: Conference Paper

References (9)

1. Morgan DJ. Drug disposition in mothers and fœetus. Clin Exp Pharmacol Physiol 1997 ; 24 : 869-73.
2. Garland M. Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin North Am 1998 ; 25 : 21-42.
3. Geber WF, Schramm LC. Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol 1975 ; 123 : 705-13.
4. Jurand A. Teratogenic activity of methadone hydrochloride in mouse and chicken embryos. J Embryol Exp Morph 1973 ; 30 : 449-58.
5. Evans RG, Olley JE, Rice GE, Abrahams JM. Effects of subacute opioid administration during late pregnancy in the rat on the initiation, duration and outcome of parturition and maternal levels of oxytocin and arginine vasopressin. Clin Exp Pharmacol Physiol 1989 ; 16 : 169-78.
6. Jarvis MAE, Schnoll SH. Methadone treatment during pregnancy. J Psychoact Drugs 1994 ; 26 : 155-61.
7. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachâtre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Therap 1997 ; 62 : 569-71.
8. Marquet P, Lavignasse P, Chevrel J, Merle L, Lachatre G. Exposition au Subutex® in utero et syndrome de manque du nouveau-ne. Toxicorama 1999 ; 11 : 17-24.
9. Marquet P. High-dose buprenorphine (HD-BU) use in pregnant women and consequences for their newborn. 52nd Annual Meeting of the American Academy of Forensic Sciences; 2000 Feb. 21-26; Reno, États-Unis. Colorado Springs Co, États-Unis : AAFS Publications.